The IPV (Inactivated Poliovirus) Vaccines Market pertains to the global manufacture, distribution and supply of vaccines that are comprised from a weakened inactivated poliovirus and are administered with the purpose of providing immunization to poliomyelitis. While the OPV still developed from a live virus that could cause polio, IPV vaccines contain killed virus meaning that they are safe for immunocompromised persons. They are usually in the form of injection and they form part of efforts being made around the world to eliminate poliomyelitis and their demand emanates from governmental immunization programs, health care facilities and public health organizations.